Vesper Healthcare Acquisition - Warrants (29/09/2025) Overview

Vesper Healthcare Acquisition - Warrants (29/09/2025) Research & Development

Research & Development expenses for VSPRW.

Quarterly R&D Expenses

$2988.00

As of Jun 30, 2021

Annual R&D Expenses (TTM)

$2988.00

Trailing 12 months ending Jun 30, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin